Abstract:Swertia plants have been considered to be medicinal plants useful for the treatment of various ailments for thousands of years, especially in Asian countries. This is due to the broad variety of chemical compounds that provide multiple ligands for bonding to different endogenous biomacromolecules for patients. Chemical constituents and pharmacological activities of Swertia plants are summarized in this paper. Approximately 419 metabolites and 40 bioactive compounds have been reported from 30 Swertia species, including xanthones, flavonoids, seco-iridiods, iridiods, triterpenoids, alkaloids, volatiles, and other secondary metabolites. The bioactivities of Swertia plants include anticarcinogenic, hepatoprotective, anti-oxidant, hypoglycemic, anthelmintic, antibacterial, antifungal, anti-diabetic, gut, and airways modulatory, metabolizing isozymes inhibitory, neuroprotective, HIV-I reverse transcriptases inhibitory, anticholinergic, and CNS-depressant activities, etc. In addition, biosynthetic pathways of xanthones, and seco-iridiods, two most important secondary metabolites for Swertia, are elucidated. The xanthones biosynthetic pathway is a mixed biosynthetic pathway involved the shikimate and the malonate routes, and the seco-iridoid pathway starts with geraniol derived from IPP which is produced either via the MEP or the MVA pathway. This review will offer a reference for future researches on the protection of natural resources, the investigation of therapeutic basis, new drug development, and so forth. Metabolic pathways of some crucial active compounds were also discussed in this review.

Iridoid Compounds from the Aerial Parts of Swertia Mussotii Franch. with Cytotoxic Activity

A New Indole Alkaloidal Glucoside from the Aerial Parts of Clematis Terniflora DC.

Four new secoiridoids from the stem barks of Syringa reticulata (Bl.) Hara

Chemical Constituents from Swertia Mussotii Franch. (Gentianaceae)

[Studies on Chemical Constituents of Swertia Mussotii].

Cytotoxic Sesquiterpene Lactones from Artemisia Myriantha

Phytochemistry and Pharmacological Activities of the Genus Swertia (Gentianaceae): A Review

Iridoid Glycosides from Saprosma Ternatum.

Chemical Constituents from the Roots of Lindera Glauca and Their Antitumor Activity on Four Different Cancer Cell Lines

A New Natural Compound with Cytotoxic Activity from Tripterygium Hypoglaucum

A New Cytotoxic Iridoid from the Rhizomes and Roots of Patrinia Heterophylla

Sesquiterpenoids from Aerial Parts of Artemisia Myriantha

Three New C-glycosyflavones with Acetyl Substitutions from Swertia Mileensis

Two unusual novel iridoid glycosides from Cornus officinalis fruit and their biological activities

8-<i>O</i>-<i></i>-D-Glucopyranosyl-2-methylchromone, a new chromone glycoside from the Tibetan medicine plant of<i>Swertia punicea</i>Hemsl

Secoiridoids from the traditional Chinese medicine Swertia pseudochinensis

The Sesquiterpenoids from Cynara Scolymus

Iridoids from Pedicularis verticillata and their anti-complementary activity.

Two new phenolic glycosides from the roots of Iris domestica (L.) Goldblatt & Mabb and their cytotoxic activity

Sesquiterpene lactones from the aerial parts of Xanthium sibiricum and their cytotoxic effects on human cancer cell lines

A New Isocoumarin Glucoside from the Aerial Parts of Aruncus sylvester